BCL2 and glioblastoma: Overexpression of BCL-2 was also commonly identified in many childhood solid tumors such as osteosarcoma [79], glioblastoma multiforme [80], Wilms’ tumor [81], and neuroblastoma [82], highlighting a significant BCL-2 involvement in the development of these cancers.